Mounjaro (tirzepatide)

https://www.helloklarity.com/wp-content/uploads/2022/07/Klarity-Logo-Brand.svg

Klarity Health, Inc

Home

Mounjaro Online Prescription For Weight Loss — Find Out How

Mounjaro is a name-brand injectable medication with the active ingredient tirzepatide.  It was U.S. Food and Drug Administration (FDA)-approved in May 2022 to be used with diet and exercise to improve glycemic (blood sugar) control for adults with type 2 diabetes.

In trials though, people didn’t just improve blood sugar control and reduce their A1C levels using Mounjaro, they also lost weight. 

Mounjaro is prescribed off-label for weight loss. And Eli Lilly got a version of tirzepatide branded as Zepbound approved just for weight loss in November 2023. 

Both Mounaro and Zepbound have become popular alongside weight loss injection medication Wegovy (semaglutide) and Ozempic (semaglutide), a med for type 2 diabetes that’s also used off-label for weight loss.